19.98MMarket Cap
LossP/E TTM
Skye Bioscience Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Skye Bioscience Inc is 6.94, ranking 237 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.39, which is -2834.24% below the recent high of 10.76 and -1209.13% above the recent low of -5.15.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.